Khaitan, Anderson Mori, Amarchand on $300m Indo-Jap Pharma sale

Thursday, 19 June 2014 By Legally India Corporate M&A

Khaitan & Co and Anderson, Mori & Tomotsune advised Japan’s Meiji Seika Pharma in buying Bangalore pharma company Medreich for Rs 1720 crore ($290m). Medreich was advised by Amarchand Mangaldas.

Khaitan corporate partner Bhavik Narsana, banking and finance partner Kumar Saurabh Singh, competition law partner Avaantika Kakkar, intellectual property partner Adheesh Nargolkar, real estate partner Abhishek Sharma and regulatory partner Sharad Vaid and Anderson Mori partners Yuichiro Nukada and Ryo Okochi acted for Meija.

Amarchand corporate partner Ashish Jejurkar and tax partner SR Patnaik acted for Medreich.

The buyout leads to the exit of the Singapore government’s investment arm Temasek which had invested Rs 109 crore in Medreich for a 25 per cent stake in 2005, reported Mint.

Amarchand, along with Luthra & Luthra, had also advised debt-ridden pharma giant Ranbaxy in being sold off to Sun Pharma two months ago.

Khaitan & CoAmarchand MangaldasAnderson Mori & Tomotsune

Comments

Jobless?!? 19 Jun 2014, 10:28
+25 -1
6 partners from KCO???!!!??? [faints]
Expensive Law Firm 19 Jun 2014, 12:16
+3 -0
You need to learn how to charge large fee
Observer 19 Jun 2014, 12:50
+3 -5
Quality does come at a cost.
ABC 19 Jun 2014, 13:18
+9 -14
you really are not into how international law firms staff on M&A transactions?

to give khaitan its due, they did report the names of all partners who contributed to the deal.
Observer 19 Jun 2014, 14:29
+25 -2
Conclusion being that Khaitan is an international firm in terms of billing and staffing transactions. However, when it comes to HR practices they remain true to their roots.
DEF 19 Jun 2014, 17:42
+12 -1
So you saying as opposed to Anderson Mori & Amarchand, whose all partners names are not reported, is it?

Me thinks, not...

KCO is just keeping their folks busy as opposed to they being idle...
Guest 21 Jun 2014, 19:00
+1 -0
if there are 6 partners for this deal, i think atleast 15 associates would have worked on it.

there name should also be given as international firms do name all the people involved in the deal.
Interested. 20 Jun 2014, 04:52
+3 -0
"Amarchand, along with Luthra & Luthra, had also advised debt-ridden pharma giant Ranbaxy in being sold off to Sun Pharma two months ago"

What is the need to add this last line? Kian?? Trying to stir up something are we?
Prachishrivastava 20 Jun 2014, 06:35
+1 -1
Hi,

Thank you for your comment. This deal and the Sun Pharma deal are both big Japanese pharma transactions this quarter, and Amarchand was on both.

Yes I was therefore definitely interested in 'stirring up' that link :)

Best wishes,
Prachi
Point to note 20 Jun 2014, 07:29
+0 -0
Interesting that in the litigation involving the Sun Pharma Ranbaxy deal, it was Khaitan representing Sun Pharma.
Yes, interested 20 Jun 2014, 07:29
+12 -0
Get a life dude ! Stirring up hardly...
Country - Japan
Sector - Pharmacueticals
Practice - M&A (and FDI)
Law Firm - Amarchand & Mangaldas....
-- 22 Jun 2014, 17:04
+0 -0
Kian:
How do I see comments which are hidden due to down voting on iPad. Can't really hover! Even though no reply may be necessary! I am curious to see what was it that many people did not like!!
kianganz 22 Jun 2014, 17:19
+0 -0
You can't tap the comment to make it appear on the iPad? If not, will look into making that work for you...
Commenting is closed for this article.